Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

24 May 2021: Meta-Analysis

Relationship of Programmed Death-1 (PD-1) and Programmed Death Ligand-1 (PD-L1) Polymorphisms with Overall Cancer Susceptibility: An Updated Meta-Analysis of 28 Studies with 60 612 Subjects

Wenjing Zhang 12BCDEF , Yuxuan Song 34ABEF* , Xiangcheng Zhang 1ACEG*

DOI: 10.12659/MSM.932146

Med Sci Monit 2021; 27:e932146

Table 4 Subgroup analyses based on cancer type.

GenotypeSubgroupnContrast modelOR (95% CI)PTest for heterogeneityAnalysis model
I2 (%)P
rs10204525Esophageal cancer4A vs G1.015 (0.862–1.195)0.85977.400.004R
GA vs GG1.063 (0.796–1.419)0.67963.700.041R
AA vs GG1.122 (0.749–1.681)0.57677.700.004R
AA+GA vs GG1.068 (0.774–1.475)0.68773.500.010R
AA vs AG+GG1.030 (0.832–1.274)0.78771.900.014R
Breast cancer1A vs G0.891 (0.745–1.064)0.202..R
GA vs GG0.976 (0.640–1.488)0.910..R
AA vs GG0.834 (0.549–1.267)0.395..R
AA+GA vs GG0.898 (0.601–1.342)0.600..R
AA vs AG+GG0.851 (0.674–1.074)0.174..R
Gastric cancer1A vs G1.085 (0.871–1.351)0.021..R
GA vs GG1.417 (0.817–2.461)0.215..R
AA vs GG1.380 (0.805–2.366)0.241..R
AA+GA vs GG1.396 (0.825–2.360)0.213..R
AA vs AG+GG1.033 (0.784–1.361)0.817..R
rs2227981Breast cancer2C vs T1.219 (1.045–1.422)0.0126.700.301R
TC vs TT1.081 (0.750–1.557)0.6770.000.408R
CC vs TT1.309 (0.910–1.883)0.1470.000.975R
CC+CT vs TT1.206 (0.852–1.707)0.2910.000.750R
CC vs CT+TT1.301 (0.991–1.706)0.05849.600.159R
Ovarian cancer2C vs T0.639 (0.241–1.694)0.36894.60R
TC vs TT0.304 (0.053–1.756)0.18388.000.004R
CC vs TT0.358 (0.063–2.054)0.24988.500.003R
CC+CT vs TT0.336 (0.058–1.942)0.22389.000.003R
CC vs CT+TT0.769 (0.390–1.516)0.44982.900.015R
rs2227982Esophageal cancer4C vs T0.982 (0.914–1.056)0.62310.200.342F
TC vs TT1.095 (0.966–1.241)0.1540.000.813F
CC vs TT0.961 (0.831–1.112)0.59215.100.316F
CC+CT vs TT1.049 (0.932–1.181)0.4240.000.613F
CC vs CT+TT0.907 (0.805–1.022)0.10811.800.334F
Breast cancer2C vs T1.173 (1.040–1.322)0.0100.000.599F
TC vs TT1.012 (0.823–1.245)0.9080.000.758F
CC vs TT1.379 (1.081–1.758)0.0100.000.734F
CC+CT vs TT1.120 (0.921–1.361)0.2570.000.980F
CC vs CT+TT1.375 (1.126–1.679)0.0020.000.536F
rs2890658Non-small cell lung2A vs C0.609 (0.477–0.777)0.0005.200.304F
CA vs CC0.777 (0.252–2.398)0.6610.000.817F
AA vs CC0.465 (0.155–1.397)0.1720.000.662F
AA+AC vs CC0.503 (0.167–1.510)0.2210.000.668F
AA vs AC+CC0.589 (0.454–0.765)0.0000.000.345F
Hepato-cellular carcinoma2A vs C1.358 (1.006–1.833)0.0460.000.629F
CA vs CC1.195 (0.430–3.323)0.7330.000.380F
AA vs CC1.648 (0.612–4.436)0.3230.000.361F
AA+AC vs CC1.516 (0.566–4.065)0.4080.000.362F
AA vs AC+CC1.405 (1.002–1.970)0.0490.000.794F
rs36094323Esophageal cancer3G vs A1.036 (0.893–1.202)0.63961.800.073R
AG vs AA1.041 (0.893–1.214)0.6080.000.960F
GG vs AA0.942 (0.789–1.125)0.5100.000.436F
GG+GA vs AA1.008 (0.872–1.165)0.9170.000.720F
GG vs GA+AA1.024 (0.810–1.295)0.84368.900.040R
Ovarian cancer2G vs A0.727 (0.523–1.012)0.05964.700.092R
AG vs AA0.695 (0.538–0.897)0.0050.000.673F
GG vs AA0.615 (0.459–0.823)0.00161.800.106F
GG+GA vs AA0.666 (0.523–0.847)0.0010.000.333F
GG vs GA+AA0.689 (0.397–1.196)0.18565.900.087R
rs4143815Gastric cancer2C vs G0.708 (0.307–1.630)0.41792.90R
GC vs GG0.449 (0.185–1.089)0.07773.900.050R
CC vs GG0.498 (0.132–1.878)0.30387.000.006R
CC+CG vs GG0.473 (0.162–1.384)0.17283.800.013R
CC vs CG+GG0.815 (0.348–1.911)0.63885.200.009R
Hepato-cellular carcinoma2C vs G0.736 (0.440–1.233)0.24581.500.020R
GC vs GG0.422 (0.279–0.639)0.0000.000.795R
CC vs GG0.459 (0.213–0.991)0.04763.500.098R
CC+CG vs GG0.425 (0.288–0.628)0.0000.000.353R
CC vs CG+GG0.864 (0.405–1.844)0.70681.000.022R
rs7421861Esophageal cancer4T vs C1.000 (0.784–1.276)0.99987.00R
TC vs CC1.179 (0.995–1.396)0.0570.000.770F
TT vs CC1.133 (0.760–1.689)0.54161.000.053R
TT+CT vs CC1.169 (0.995–1.374)0.05830.000.232F
TT vs CT+CC0.984 (0.735–1.317)0.91383.000.001R
Breast cancer2T vs C0.960 (0.784–1.175)0.69242.100.189R
TC vs CC1.183 (0.730–1.917)0.4940.000.923F
TT vs CC1.123 (0.701–1.798)0.6300.000.701R
TT+CT vs CC1.169 (0.995–1.374)0.5860.000.807F
TT vs CT+CC0.931 (0.729–1.189)0.56546.100.173R

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750